2022 Annual Meeting | C13 - Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia
Program Materials Program Evaluations
12:15 PM - 12:40 PM PDT | Speaker |
AChR Positive Myasthenia Gravis
Srikanth Muppidi, MD, FAAN |
12:15 PM - 02:15 PM PDT | Speaker |
walk in slides
Srikanth Muppidi, MD, FAAN |
12:40 PM - 01:05 PM PDT | Speaker |
MuSK and Ocular Myasthenia Gravis
Neelam Goyal, MD |
01:05 PM - 01:30 PM PDT | Speaker |
Complement Inhibition in Myasthenia Gravis
Srikanth Muppidi, MD, FAAN |
01:30 PM - 01:55 PM PDT | Speaker |
FCRN Antagonism in Myasthenia Gravis
Neelam Goyal, MD |
01:55 PM - 02:15 PM PDT | Q&A |
Questions and Answers
Srikanth Muppidi, MD, FAAN, Neelam Goyal, MD |
Srikanth Muppidi, MD, FAAN | Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. muppidi has received publishing royalties from a publication relating to health care. |
Neelam Goyal, MD | Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx. |